BFS
CRL icon

Bare Financial Services’s Charles River Laboratories CRL Stock Holding History

Bare Financial Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$518 – 1815
2026
Q1 		$518 Buy
3
+1
+50% +$185 ﹤0.01% 1503
2025
Q4 		$399 Sell
2
-8
-80% -$1.45K ﹤0.01% 1497
2025
Q3 		$1.56K Buy
10
+3
+43% +$476 ﹤0.01% 882
2025
Q2 		$1.06K Buy
7
+4
+133% +$533 ﹤0.01% 905
2025
Q1 		$452 Buy
+3
New +$503 ﹤0.01% 865

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Bare Financial Services's CRL Position: Q2 2026 in Review

Bare Financial Services sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 3 shares — an estimated $518 sold.

Bare Financial Services first reported a position in CRL in Q1 2025 and held it in 5 quarters. The position peaked at $1.56K in Q3 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Bare Financial Services reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Bare Financial Services sold 3 Charles River Laboratories shares in Q2 2026, an estimated $518.
  • Bare Financial Services first reported a position in Charles River Laboratories in Q1 2025 and held it in 5 quarters.
  • Bare Financial Services's Charles River Laboratories position peaked at $1.56K in Q3 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.